US1511902041 - Common Stock
CELULARITY INC-A
NASDAQ:CELU (5/3/2024, 7:00:00 PM)
3.29
+0.17 (+5.45%)
Celularity, Inc. a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. The company is headquartered in Florham Park, New Jersey and currently employs 225 full-time employees. The company went IPO on 2019-05-23. The firm is engaged in developing off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. The company operates through three business segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapy product candidates include T cells engineered with a chimeric antigen receptor (CAR), natural killer, cells, mesenchymal-like adherent stromal cells (MLASCs), and exosomes. These therapeutic candidates target indications across cancer, infectious and degenerative diseases. Its cell therapeutic programs include CYCART-19, CYCART-201, CYNK-001, CYNK-301, CYNK-302, APPL-001, and pEXO-001. CYCART-19 is a placental-derived CAR-T cell therapy, in development for the treatment of B-cell malignancies, initially targeting the cluster of differentiation 19. pExo-001 is developed for the treatment of osteoarthritis. APPL-001 is developed for the treatment of Crohn’s disease.
CELULARITY INC-A
170 Park Ave
Florham Park NEW JERSEY
P: 19087682170
Employees: 225
Website: https://celularity.com/
Event Will Be Hosted On-site and Aired Virtually Highlighting Research, Clinical and Commercial Progress
Event Will Be Hosted On-site and Aired Virtually Highlighting Research, Clinical and Commercial Progress...
FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing...
FLORHAM PARK, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative medicine company developing...
Company Presenting at ASGCT Annual Meeting...
Here you can normally see the latest stock twits on CELU, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: